Clinical adverse effects of sodium-glucose cotransporter 2 inhibitors: Protocol for a systematic review and meta-analysis

about

Clinical adverse effects of sodium-glucose cotransporter 2 inhibitors: Protocol for a systematic review and meta-analysis

Item

http://www.wikidata.org/entity/Q58789064

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Clinical adverse effects of so ...... matic review and meta-analysis

@en

Clinical adverse effects of so ...... matic review and meta-analysis

@nl

type

Item

label

Clinical adverse effects of so ...... matic review and meta-analysis

@en

Clinical adverse effects of so ...... matic review and meta-analysis

@nl

prefLabel

Clinical adverse effects of so ...... matic review and meta-analysis

@en

Clinical adverse effects of so ...... matic review and meta-analysis

@nl

P1476

Clinical adverse effects of so ...... matic review and meta-analysis

@en

P2093

Fang-Hong Shi

http://www.w3.org/2001/XMLSchema#string

Shi-Ying Huang

http://www.w3.org/2001/XMLSchema#string

Shun-Guo Zhang

http://www.w3.org/2001/XMLSchema#string

Zhi-Chun Gu

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

Osmotic diuresis with SGLT2 inhibition: analysis of events related to volume reduction in dapagliflozin clinical trials.

A novel approach to control hyperglycemia in type 2 diabetes: sodium glucose co-transport (SGLT) inhibitors: systematic review and meta-analysis of randomized trials.

Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program.

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

Sodium-glucose co-transporter-2 inhibitors and risk of adverse renal outcomes among patients with type 2 diabetes: A network and cumulative meta-analysis of randomized controlled trials.

Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials.

Recent trends in the prevalence of type 2 diabetes and the association with abdominal obesity lead to growing health disparities in the USA: An analysis of the NHANES surveys from 1999 to 2014.

8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2018.

P304

e11853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1097/MD.0000000000011853

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hao Li

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30095664

http://www.w3.org/2001/XMLSchema#string

P921

glucose

P932

6133482

http://www.w3.org/2001/XMLSchema#string